We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Enbridge
ENB
$113B
| $592K | ﹤0.01% |
12,371
+8,088
| +189% | +$386K |
|
2152
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $590K | ﹤0.01% |
18,900
+7,800
| +70% | +$192K |
|
2153
La-Z-Boy
LZB
$1.66B
| $588K | ﹤0.01% |
15,785
-100,987
| -86% | -$3.54M |
|
2154
AC Immune
ACIU
$259M
| $586K | ﹤0.01% |
+186,709
| New | +$589K |
|
|
FFWM
2155
DELISTED
First Foundation Inc
FFWM
| $583K | ﹤0.01% |
94,562
+9,846
| +12% | +$55.1K |
|
|
NVX
2156
NOVONIX
NVX
$112M
| $582K | ﹤0.01% |
+575,816
| New | +$817K |
|
2157
PMV Pharmaceuticals
PMVP
$69.3M
| $581K | ﹤0.01% |
465,086
-147,540
| -24% | -$198K |
|
|
OGG
2158
Osisko Gold Group Inc.
OGG
$829M
| $581K | ﹤0.01% |
166,467
-647,065
| -80% | -$2.22M |
|
2159
Strawberry Fields REIT
STRW
$193M
| $577K | ﹤0.01% |
44,058
-7,851
| -15% | -$96.1K |
|
2160
Planet Fitness
PLNT
$3.62B
| $575K | ﹤0.01% |
5,300
-6,800
| -56% | -$700K |
|
2161
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
| $575K | ﹤0.01% |
5,300
+500
| +10% | +$53.7K |
|
2162
Dimensional US Targeted Value ETF
DFAT
$14.7B
| $575K | ﹤0.01% |
+9,653
| New | +$563K |
|
2163
J. Jill
JILL
$284M
| $573K | ﹤0.01% |
41,791
+4,346
| +12% | +$65.7K |
|
2164
Turning Point Brands
TPB
$1.77B
| $566K | ﹤0.01% |
5,222
-2,455
| -32% | -$240K |
|
2165
California Resources
CRC
$4.81B
| $566K | ﹤0.01% |
12,660
-601,134
| -98% | -$28.5M |
|
|
LENZ
2166
LENZ Therapeutics
LENZ
$163M
| $564K | ﹤0.01% |
+35,252
| New | +$1.03M |
|
2167
Betterware México
BWMX
$607M
| $564K | ﹤0.01% |
39,667
-31,749
| -44% | -$438K |
|
2168
NatWest
NWG
$75.8B
| $561K | ﹤0.01% |
+32,063
| New | +$508K |
|
|
CVSA
2169
Covista Inc
CVSA
$4.31B
| $561K | ﹤0.01% |
+5,419
| New | +$621K |
|
2170
Mesa Laboratories
MLAB
$622M
| $560K | ﹤0.01% |
7,137
-7,463
| -51% | -$568K |
|
2171
GE Aerospace
GE
$382B
| $560K | ﹤0.01% |
+1,818
| New | +$547K |
|
2172
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$305M
| $556K | ﹤0.01% |
+36,066
| New | +$556K |
|
2173
Full House Resorts
FLL
$86.8M
| $553K | ﹤0.01% |
211,982
-59,827
| -22% | -$161K |
|
2174
Customers Bancorp
CUBI
$2.8B
| $553K | ﹤0.01% |
7,566
-46,733
| -86% | -$3.21M |
|
2175
Goldman Sachs BDC
GSBD
$1.09B
| $553K | ﹤0.01% |
59,580
-378,074
| -86% | -$3.71M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.